ClearPoint Neuro
CLPT • NASDAQ
ClearPoint Neuro is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Joseph Michael Burnett, with a market cap of $269.1M.
CEOJoseph Michael Burnett
Next Earnings
Upcoming earnings announcement for ClearPoint Neuro
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.26
Revenue Estimate
$12.2M
Earnings History
Past 12 earnings reports for ClearPoint Neuro
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.23Est: -$0.21 | -9.5% | $10.4MEst: $9.9M | +4.9% | — |
| Nov 6, 2025 | Q3 2025 | -$0.21Est: -$0.20 | -5.0% | $8.9MEst: $9.7M | -8.8% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.21Est: -$0.20 | -5.0% | $9.2MEst: $9.3M | -1.1% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.22Est: -$0.16 | -37.5% | $8.5MEst: $8.2M | +3.5% | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.20Est: -$0.16 | -25.0% | $7.8MEst: $8.2M | -5.6% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.18Est: -$0.17 | -5.9% | $8.1MEst: $7.8M | +4.4% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.16Est: -$0.20 | +20.0% | $7.9MEst: $7.3M | +7.2% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.16Est: -$0.19 | +15.8% | $7.6MEst: $7.0M | +9.3% | 10-Q |
| Mar 12, 2024 | Q4 2023 | -$0.19Est: -$0.20 | +5.0% | $6.8MEst: $6.5M | +4.3% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.20Est: -$0.25 | +20.0% | $5.8MEst: $6.8M | -15.3% | — |
| Aug 8, 2023 | Q2 2023 | -$0.29Est: -$0.19 | -52.6% | $6.0MEst: $5.9M | +0.8% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.23Est: -$0.18 | -27.8% | $5.4MEst: $5.1M | +6.5% | 10-Q |